Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Estimating Radiotherapy-Induced Secondary Cancer Risk Arising From Brain Irradiation at High Energy: A Monte Carlo Study Publisher



Elmtalab S1, 2 ; Karimi AH3 ; Mehr FSK4 ; Zamani H5 ; Abedi I2 ; Pashaei F1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Radiation Sciences Research Center, Aja University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Physics, School of Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Quantitative Magnetic Resonance Imaging and Spectroscopy Group, Research Centre for Molecular and Cellular Imaging, Advanced Medical Technologies and Equipment Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medical Physics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Source: Frontiers in Biomedical Technologies Published:2022


Abstract

Purpose: The present study aims to determine the whole-body out-of-field photon dose equivalents of high-energy conventional radiation therapy treatment. Also, it is tried to estimate the probability of fatal secondary cancer risk for the susceptible organs using a Monte Carlo (MC) code. Materials and Methods: A Monte Carlo N-Particle eXtended (MCNPX)-based model of 18-MV Medical Linear Accelerator (LINAC) was created to calculate the out-of-field photon dose equivalent at the locations of fascinating organs in the mathematical female Medical Internal Radiation Dosimetry (MIRD) phantom. Then, the secondary malignancies risk was estimated based on out-of-field doses and radiation risk coefficients according to the National Council of Radiation Protection and Measurements (NCRP). Results: The average photon equivalent dose in out-of-field organs was about 3.25 mSv/Gy, ranging from 0.23 to 37.2 mSv/Gy, respectively, for the organs far from the Planning Target Volume (PTV) (Rectum) and those close to the treatment field (Eyes). The entire secondary cancer risk for the 60 Gy prescribed dose to isocenter was obtained as 2.9987%. Here, the maximum risk among off-field organs was related to stomach (0.0805%), lung (0.0601%), and thyroid (0.0404%). Conclusion: Regarding the estimated values for the probability of secondary cancer risk, it is suggested to perform a long-term follow-up of brain cancer patients regarding the prevalence of thyroid, stomach, and lung cancer after completing the treatment course. Copyright © 2022 Tehran University of Medical Sciences.
Related Docs
1. Monte Carlo Evaluation of Out-Of-Field Dose in 18 Mv Pelvic Radiotherapy Using a Simplified Female Mird Phantom, Biomedical Physics and Engineering Express (2022)
2. Semi-Experimental Assessment of Neutron Equivalent Dose and Secondary Cancer Risk for Off-Field Organs in Glioma Patients Undergoing 18-Mv Radiotherapy, PLoS ONE (2022)
3. Feasibility of 18-Mv Grid Therapy From Radiation Protection Aspects: Unwanted Dose and Fatal Cancer Risk Caused by Photoneutrons and Scattered Photons, Computer Methods and Programs in Biomedicine (2022)
4. Measurement of Neutron Equivalent Dose in the Thyroid, Chiasma, and Lens for Patients Undergoing Pelvic Radiotherapy: A Phantom Study, Applied Radiation and Isotopes (2022)
5. Assessing the Risk of Secondary Cancer Induction in Radiosensitive Organs During Trigeminal Neuralgia Treatment With Gamma Knife Radiosurgery: Impact of Extracranial Dose, Dose-Response (2023)
6. How Much Should You Worry About Contaminant Neutrons in Spatially Fractionated Grid Radiation Therapy?, PLoS ONE (2023)
7. Dose Equivalent Consideration From Neutron Contamination in Modified Radiotherapy Vault: A Monte Carlo Study, Biomedical Physics and Engineering Express (2024)
Experts (# of related papers)
Ghazaleh Geraily (6)
Ali Kazemian (1)